Mr. Marc-Andre Massue reports

DIAGNOS ANNOUNCES AMENDMENT TO ITS STOCK OPTION PLAN

The board of directors of Diagnos Inc. has approved an amendment to the corporation's stock option plan in order to increase the maximum number of common shares that may be issued pursuant thereto from 12 million to 20 million to provide long-term incentives aimed at achieving the corporation's growth plans.

This amendment is subject to TSX Venture Exchange acceptance and disinterested shareholder approval at the annual general meeting of shareholders scheduled for Sept. 24, 2015.